Loading company…
Porton Biologics provides contract development and manufacturing services for gene and cell therapies.
Porton Biologics provides gene and cell therapy CDMO services, including plasmid, cell therapy, gene therapy, nucleic acid, and bacteriophage work. Based in Suzhou, China, it raised Series B funding in August 2022 to develop its platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in